These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15531098)

  • 21. Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway.
    Szabadfi K; Reglodi D; Szabo A; Szalontai B; Valasek A; Setalo G; Kiss P; Tamas A; Wilhelm M; Gabriel R
    Neurotox Res; 2016 Apr; 29(3):432-46. PubMed ID: 26739825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the PKA-Bad-14-3-3 signaling pathway in glutamate-induced retinal injury in neonatal rats.
    Rácz B; Gallyas F; Kiss P; Tamás A; Lubics A; Lengvári I; Röth E; Tóth G; Hegyi O; Verzál Z; Fabricsek C; Reglódi D
    Neurotox Res; 2007 Sep; 12(2):95-104. PubMed ID: 17967733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury.
    Farkas O; Tamás A; Zsombok A; Reglodi D; Pál J; Büki A; Lengvári I; Povlishock JT; Dóczi T
    Regul Pept; 2004 Dec; 123(1-3):69-75. PubMed ID: 15518895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes.
    Shieh PC; Tsao CW; Li JS; Wu HT; Wen YJ; Kou DH; Cheng JT
    Neurosci Lett; 2008 Mar; 434(1):1-5. PubMed ID: 18313848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effects of the neuropeptide PACAP in diabetic retinopathy.
    Szabadfi K; Atlasz T; Kiss P; Reglodi D; Szabo A; Kovacs K; Szalontai B; Setalo G; Banki E; Csanaky K; Tamas A; Gabriel R
    Cell Tissue Res; 2012 Apr; 348(1):37-46. PubMed ID: 22350850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective effect of citicoline against KA-induced neurotoxicity in the rat retina.
    Park CH; Kim YS; Noh HS; Cheon EW; Yang YA; Yoo JM; Choi WS; Cho GJ
    Exp Eye Res; 2005 Sep; 81(3):350-8. PubMed ID: 16129102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective effect of PACAP against kainic acid-induced neurotoxicity in rat retina.
    Seki T; Nakatani M; Taki C; Shinohara Y; Ozawa M; Nishimura S; Ito H; Shioda S
    Ann N Y Acad Sci; 2006 Jul; 1070():531-4. PubMed ID: 16888220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice.
    Sándor K; Bölcskei K; McDougall JJ; Schuelert N; Reglodi D; Elekes K; Petho G; Pintér E; Szolcsányi J; Helyes Z
    Pain; 2009 Jan; 141(1-2):143-50. PubMed ID: 19091468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo.
    Szabadfi K; Atlasz T; Kiss P; Danyadi B; Tamas A; Helyes Z; Hashimoto H; Shintani N; Baba A; Toth G; Gabriel R; Reglodi D
    Neurotox Res; 2012 Jan; 21(1):41-8. PubMed ID: 21717232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effects of vasoactive intestinal peptide (VIP) in ischemic retinal degeneration.
    Szabadfi K; Danyadi B; Kiss P; Tamas A; Fabian E; Gabriel R; Reglodi D
    J Mol Neurosci; 2012 Nov; 48(3):501-7. PubMed ID: 22544514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of PACAP in UV-A radiation-induced retinal degeneration models in rats.
    Atlasz T; Szabadfi K; Kiss P; Marton Z; Griecs M; Hamza L; Gaal V; Biro Z; Tamas A; Hild G; Nyitrai M; Toth G; Reglodi D; Gabriel R
    J Mol Neurosci; 2011 Jan; 43(1):51-7. PubMed ID: 20521124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of PACAP on MAP kinases, Akt and cytokine expressions in rat retinal hypoperfusion.
    Szabo A; Danyadi B; Bognar E; Szabadfi K; Fabian E; Kiss P; Mester L; Manavalan S; Atlasz T; Gabriel R; Toth G; Tamas A; Reglodi D; Kovacs K
    Neurosci Lett; 2012 Aug; 523(2):93-8. PubMed ID: 22750211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates.
    Jolivel V; Basille M; Aubert N; de Jouffrey S; Ancian P; Le Bigot JF; Noack P; Massonneau M; Fournier A; Vaudry H; Gonzalez BJ; Vaudry D
    Neuroscience; 2009 May; 160(2):434-51. PubMed ID: 19236905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular Delivery of PACAP1-27 Protects the Retina From Ischemic Damage in Rodents.
    Werling D; Reglodi D; Banks WA; Salameh TS; Kovacs K; Kvarik T; Vaczy A; Kovacs L; Mayer F; Danyadi B; Lokos E; Tamas A; Toth G; Biro Z; Atlasz T
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6683-6691. PubMed ID: 27936470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The presence and distribution of pituitary adenylate cyclase activating polypeptide and its receptor in the snail Helix pomatia.
    Hernádi L; Pirger Z; Kiss T; Németh J; Mark L; Kiss P; Tamas A; Lubics A; Toth G; Shioda S; Reglodi D
    Neuroscience; 2008 Aug; 155(2):387-402. PubMed ID: 18590802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis.
    Gasz B; Rácz B; Roth E; Borsiczky B; Ferencz A; Tamás A; Cserepes B; Lubics A; Gallyas F; Tóth G; Lengvári I; Reglodi D
    Peptides; 2006 Jan; 27(1):87-94. PubMed ID: 16095757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
    Mounien L; Bizet P; Boutelet I; Gourcerol G; Fournier A; Vaudry H; Jégou S
    Neuroscience; 2006 Nov; 143(1):155-63. PubMed ID: 16962718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of PACAP in 6-OHDA-induced injury of the substantia nigra in intact young and ovariectomized female rats.
    Reglödi D; Lubics A; Kiss P; Lengvári I; Gaszner B; Tóth G; Hegyi O; Tamás A
    Neuropeptides; 2006 Aug; 40(4):265-74. PubMed ID: 16904179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ischemia results 3 months later in altered ERG, degeneration of inner layers, and deafferented tectum: neuroprotection with brimonidine.
    Mayor-Torroglosa S; De la Villa P; Rodríguez ME; López-Herrera MP; Avilés-Trigueros M; García-Avilés A; de Imperial JM; Villegas-Pérez MP; Vidal-Sanz M
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3825-35. PubMed ID: 16186370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular, cellular, and functional characterizations of pituitary adenylate cyclase-activating polypeptide and its receptors in the cerebellum of New and Old World monkeys.
    Aubert N; Basille M; Falluel-Morel A; Vaudry D; Bucharles C; Jolivel V; Fisch C; De Jouffrey S; Le Bigot JF; Fournier A; Vaudry H; Gonzalez BJ
    J Comp Neurol; 2007 Oct; 504(4):427-39. PubMed ID: 17663433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.